ADVANCED PHARMACOLOGY FOR
T T T
PRESCRIBERS 1ST EDITION BY LUO K
T T T T T
AYINGO TEST BANK | 2024 UPDATE
T T T T T
, Table of Contents
T T
ChapterT 1:T AnTIntroductionTtoT Evidence-BasedT ClinicalT PracticeT Guidelines ............................................. 3
ChapterT 2:TPharmacokineticsT /Chapter3:T Pharmacodynamics.................................................................... 13
Chapter4:T PharmacogeneticsT andTPharmacogenomics ............................................................................... 25
ChapterT 5:TPharmacologyT AcrossT theTLifeTSpan ........................................................................................ 30
ChapterT 6:TDrug-TherapyTPrescribingTinTSpecialT Populations ................................................................... 36
ChapterT 7:T DrugTDevelopmentT andTApproval ............................................................................................ 45
ChapterT 8-ChapterT 10:TFoundationsT ofT PrescriptionTWritingT ChapterT 9:T ResponsibleControlled-
SubstanceTPrescribingTChapterT10:TAntibioticTStewardship ....................................................................... 51
ChapterT 11:T AppliedTCalculationsT forT Prescribing ..................................................................................... 58
ChapterT 12-:TPromotingT AdherenceTWithTPharmacotherapyT II:T System-SpecificT andTPatient-
FocusedTPrescribingTChapterT 13:T PharmacotherapyTforT Ear,T Nose,T Mouth,T andThroatT ConditionsT/Chapte
rT 14:TPharmacotherapyTforTEyeTConditions ................................................................................................ 67
ChapterT 15:T PharmacotherapyT forT SkinT Conditions ................................................................................... 74
ChapterT 16:TPharmacotherapyT forT NeurologicT Conditions ......................................................................... 81
ChapterT 17:T PharmacotherapyT forT CardiovascularT Conditions .................................................................. 94
ChapterT 18:T PharmacotherapyT forT RespiratoryT Conditions ...................................................................... 106
ChapterT 19:T PharmacotherapyT forT GastrointestinalT ConditionsT andT ConditionsT RequiringNutritionalTSupp
ort .............................................................................................................................................................. 117
ChapterT 20:TPharmacotherapyT forT GenitourinaryT Conditions .................................................................. 128
ChapterT 21:T PharmacotherapyTforT Renal,T Acid–Base,T Fluid,T andTElectrolyteTDisorders ........................ 133
ChapterT 22:T PharmacotherapyT forT MusculoskeletalT andT RheumatologicT Conditions .............................. 146
ChapterT 23:TTherapeuticT ApplicationsT ofT ImmunologyT andT Vaccines .................................................... 158
ChapterT 24:TPharmacotherapyT forT EndocrineTDisorders .......................................................................... 163
ChapterT 25:TPharmacotherapyT forT HematologicT Disorders ...................................................................... 174
ChapterT 26:T Hematology/OncologyT andTSupportiveT CareTforT theTNononcologist ................................... 190
ChapterT 27:TPharmacotherapyT RelatedT toTWomen’sT HealthT Conditions ................................................. 196
ChapterT 28:T PharmacotherapyT RelatedTtoTMen’sT HealthT Conditions ....................................................... 211
ChapterT 29:T PharmacotherapyT RelatedT toTTransgenderT Care................................................................... 217
ChapterT 30:T AntimicrobialTPharmacotherapy ........................................................................................... 224
ChapterT 31:TAntiretroviralTPharmacotherapy ........................................................................................... 235
ChapterT32:TPsychopharmacologyTandTIntegrativeTHealth:TCombinedTTreatmentTofPsychiatricTandTNeuroc
ognitiveTConditions ................................................................................................................................... 247
ChapterT 33:TPharmacotherapyT forT PainTManagement .............................................................................. 257
ChapterT 34:TSubstanceT UseTDisorderT III:T HealthTPromotionT andTMaintenance ....................................... 267
ChapterT 35:TOver-the-CounterT Medications ............................................................................................. 283
ChapterT 36:T PharmacotherapyT forT Obesity ............................................................................................... 291
,ChapterT1:T AnT IntroductionT toT Evidence-BasedT ClinicalTPracticeT Guidelines
MULTIPLETCHOICE
• WhatTisTtheTprimaryT purposeT ofTtheT nursingT assessment?
A. IdentifyingT underlyingT pathologicT conditions
B. AssistingT theT physicianT inTidentifyingT medicalT conditions
C. DeterminingT theT patientsTmentalTstatus
D. ExploringT patientT responsesT toT healthT problems
ANS:TD
ATnursingT assessmentT isT doneTtoTidentifyTtheT patientsT responseT toThealthTpr
oblems.TDuringTtheTnursingT assessmentT phase,TaTcomprehensiveTinformatio
nTbaseT isT developedTthroughTaT physicalTexamination,T nursingThistory,T medi
cationThistory,T andTprofessionalT observation.T IdentifyingTunderlyingT pathol
ogicT conditionsT andT assistingT theTphysicianT inT identifyingTmedicalTconditio
nsT isT notTpartTofTtheT nursingTprocess.T DeterminingT theTpatientsT mentalTstatu
sT isT oneT partT ofTtheT nursingT assessment,T butT itT isT notTtheTprimaryTpurpose.
DIF:T CognitiveT Level:T ComprehensionT
REF:TdmT 36TOBJ:T1T |T3TTOP:TNursingT
ProcessTStep:TAssessment
MSC:TNCLEXT ClientT NeedsT Category:T HealthTPromotionT andT Maintenance
• WhatTisTtheTbasisT ofTtheT NANDATIT taxonomy?
A. FunctionalT healthTpatterns
B. HumanTresponseT patterns
C. BasicT humanT needs
D. PathophysiologicT needs
ANS:TB
TheTNANDATITtaxonomyT identifiesT humanT responseT patterns.TFunction
alTcomponentsTofThealthTpatternsTareTlimitedTtoTactivity,TfluidTvolume,Tnut
rition,TselfTcare,TandTsensoryTperception.TBasicThumanTneedsTcompriseTles
sTthanTmerelyThealthTpatterns.T PathophysiologicTneedsT areTnotTpartTofTthe
T scopeT ofTNANDATI.
, DIF:TCognitiveT Level:T KnowledgeT
REF:Tpp.T37-38TOBJ:T5TTOP:
NursingTProcessTStep:TDiagnosis
MSC:TNCLEXT ClientT NeedsT Category:T PhysiologicalT Integrity
• WhichTtaskT isTincludedT inTtheTassessmentT stepT ofTtheT nursingT process?
A. EstablishingT patientT goals/outcomes
B. ImplementingT theT nursingT careT planT (NCP)
C. MeasuringT goal/outcomeT achievement
D. CollectingT andT communicatingT data
ANS:TD
DataT areTcollectedTandT communicatedT inTtheT assessmentT phaseT ofTtheTnursi
ngTprocess.T EstablishingT goalsT isTtheTfunctionT ofT planning.
ImplementingT theT NCPTisT theT functionT ofT implementation.T MeasuringToutc
omeTachievementT isT theTfunctionTofTevaluation.
DIF:T CognitiveT Level:T ComprehensionT
REF:TdmT 36TOBJ:T2T |T3TTOP:TNursingT
ProcessTStep:TAssessment
MSC:TNCLEXT ClientT NeedsT Category:T HealthTPromotionT andT Maintenance
• WhichTstatementT regardingT nursingT diagnosesT isT accurate?
a. NursingT diagnosesT remainTtheTsameT forTasT longTasTtheTdiseaseT isT present.
b. NursingT diagnosesT areT writtenTtoT identifyTdiseaseTstates.
c. NursingT diagnosesT describeT patientT problemsT thatT nursesT treat.
d. NursingT diagnosesT identifyT causesT relatedT toTillness.
ANS:TC
DiagnosticT statementsT identifyT problemsT aT nurseT isT independentlyT ableT toTt
reatT withinTtheT scopeT ofTprofessionalTpractice.T NursingT diagnosesT varyTwit
hTtheTchangingT conditionTofTtheT patient.TTheTresponseT patternsT areTuniqueT
toTtheTpatientT andTareT notTdiseaseT specific.TNursingT diagnosesTdescribeTtheT
patientsT humanTresponseTpattern.
DIF:T CognitiveT Level:T Comprehension
T T T
PRESCRIBERS 1ST EDITION BY LUO K
T T T T T
AYINGO TEST BANK | 2024 UPDATE
T T T T T
, Table of Contents
T T
ChapterT 1:T AnTIntroductionTtoT Evidence-BasedT ClinicalT PracticeT Guidelines ............................................. 3
ChapterT 2:TPharmacokineticsT /Chapter3:T Pharmacodynamics.................................................................... 13
Chapter4:T PharmacogeneticsT andTPharmacogenomics ............................................................................... 25
ChapterT 5:TPharmacologyT AcrossT theTLifeTSpan ........................................................................................ 30
ChapterT 6:TDrug-TherapyTPrescribingTinTSpecialT Populations ................................................................... 36
ChapterT 7:T DrugTDevelopmentT andTApproval ............................................................................................ 45
ChapterT 8-ChapterT 10:TFoundationsT ofT PrescriptionTWritingT ChapterT 9:T ResponsibleControlled-
SubstanceTPrescribingTChapterT10:TAntibioticTStewardship ....................................................................... 51
ChapterT 11:T AppliedTCalculationsT forT Prescribing ..................................................................................... 58
ChapterT 12-:TPromotingT AdherenceTWithTPharmacotherapyT II:T System-SpecificT andTPatient-
FocusedTPrescribingTChapterT 13:T PharmacotherapyTforT Ear,T Nose,T Mouth,T andThroatT ConditionsT/Chapte
rT 14:TPharmacotherapyTforTEyeTConditions ................................................................................................ 67
ChapterT 15:T PharmacotherapyT forT SkinT Conditions ................................................................................... 74
ChapterT 16:TPharmacotherapyT forT NeurologicT Conditions ......................................................................... 81
ChapterT 17:T PharmacotherapyT forT CardiovascularT Conditions .................................................................. 94
ChapterT 18:T PharmacotherapyT forT RespiratoryT Conditions ...................................................................... 106
ChapterT 19:T PharmacotherapyT forT GastrointestinalT ConditionsT andT ConditionsT RequiringNutritionalTSupp
ort .............................................................................................................................................................. 117
ChapterT 20:TPharmacotherapyT forT GenitourinaryT Conditions .................................................................. 128
ChapterT 21:T PharmacotherapyTforT Renal,T Acid–Base,T Fluid,T andTElectrolyteTDisorders ........................ 133
ChapterT 22:T PharmacotherapyT forT MusculoskeletalT andT RheumatologicT Conditions .............................. 146
ChapterT 23:TTherapeuticT ApplicationsT ofT ImmunologyT andT Vaccines .................................................... 158
ChapterT 24:TPharmacotherapyT forT EndocrineTDisorders .......................................................................... 163
ChapterT 25:TPharmacotherapyT forT HematologicT Disorders ...................................................................... 174
ChapterT 26:T Hematology/OncologyT andTSupportiveT CareTforT theTNononcologist ................................... 190
ChapterT 27:TPharmacotherapyT RelatedT toTWomen’sT HealthT Conditions ................................................. 196
ChapterT 28:T PharmacotherapyT RelatedTtoTMen’sT HealthT Conditions ....................................................... 211
ChapterT 29:T PharmacotherapyT RelatedT toTTransgenderT Care................................................................... 217
ChapterT 30:T AntimicrobialTPharmacotherapy ........................................................................................... 224
ChapterT 31:TAntiretroviralTPharmacotherapy ........................................................................................... 235
ChapterT32:TPsychopharmacologyTandTIntegrativeTHealth:TCombinedTTreatmentTofPsychiatricTandTNeuroc
ognitiveTConditions ................................................................................................................................... 247
ChapterT 33:TPharmacotherapyT forT PainTManagement .............................................................................. 257
ChapterT 34:TSubstanceT UseTDisorderT III:T HealthTPromotionT andTMaintenance ....................................... 267
ChapterT 35:TOver-the-CounterT Medications ............................................................................................. 283
ChapterT 36:T PharmacotherapyT forT Obesity ............................................................................................... 291
,ChapterT1:T AnT IntroductionT toT Evidence-BasedT ClinicalTPracticeT Guidelines
MULTIPLETCHOICE
• WhatTisTtheTprimaryT purposeT ofTtheT nursingT assessment?
A. IdentifyingT underlyingT pathologicT conditions
B. AssistingT theT physicianT inTidentifyingT medicalT conditions
C. DeterminingT theT patientsTmentalTstatus
D. ExploringT patientT responsesT toT healthT problems
ANS:TD
ATnursingT assessmentT isT doneTtoTidentifyTtheT patientsT responseT toThealthTpr
oblems.TDuringTtheTnursingT assessmentT phase,TaTcomprehensiveTinformatio
nTbaseT isT developedTthroughTaT physicalTexamination,T nursingThistory,T medi
cationThistory,T andTprofessionalT observation.T IdentifyingTunderlyingT pathol
ogicT conditionsT andT assistingT theTphysicianT inT identifyingTmedicalTconditio
nsT isT notTpartTofTtheT nursingTprocess.T DeterminingT theTpatientsT mentalTstatu
sT isT oneT partT ofTtheT nursingT assessment,T butT itT isT notTtheTprimaryTpurpose.
DIF:T CognitiveT Level:T ComprehensionT
REF:TdmT 36TOBJ:T1T |T3TTOP:TNursingT
ProcessTStep:TAssessment
MSC:TNCLEXT ClientT NeedsT Category:T HealthTPromotionT andT Maintenance
• WhatTisTtheTbasisT ofTtheT NANDATIT taxonomy?
A. FunctionalT healthTpatterns
B. HumanTresponseT patterns
C. BasicT humanT needs
D. PathophysiologicT needs
ANS:TB
TheTNANDATITtaxonomyT identifiesT humanT responseT patterns.TFunction
alTcomponentsTofThealthTpatternsTareTlimitedTtoTactivity,TfluidTvolume,Tnut
rition,TselfTcare,TandTsensoryTperception.TBasicThumanTneedsTcompriseTles
sTthanTmerelyThealthTpatterns.T PathophysiologicTneedsT areTnotTpartTofTthe
T scopeT ofTNANDATI.
, DIF:TCognitiveT Level:T KnowledgeT
REF:Tpp.T37-38TOBJ:T5TTOP:
NursingTProcessTStep:TDiagnosis
MSC:TNCLEXT ClientT NeedsT Category:T PhysiologicalT Integrity
• WhichTtaskT isTincludedT inTtheTassessmentT stepT ofTtheT nursingT process?
A. EstablishingT patientT goals/outcomes
B. ImplementingT theT nursingT careT planT (NCP)
C. MeasuringT goal/outcomeT achievement
D. CollectingT andT communicatingT data
ANS:TD
DataT areTcollectedTandT communicatedT inTtheT assessmentT phaseT ofTtheTnursi
ngTprocess.T EstablishingT goalsT isTtheTfunctionT ofT planning.
ImplementingT theT NCPTisT theT functionT ofT implementation.T MeasuringToutc
omeTachievementT isT theTfunctionTofTevaluation.
DIF:T CognitiveT Level:T ComprehensionT
REF:TdmT 36TOBJ:T2T |T3TTOP:TNursingT
ProcessTStep:TAssessment
MSC:TNCLEXT ClientT NeedsT Category:T HealthTPromotionT andT Maintenance
• WhichTstatementT regardingT nursingT diagnosesT isT accurate?
a. NursingT diagnosesT remainTtheTsameT forTasT longTasTtheTdiseaseT isT present.
b. NursingT diagnosesT areT writtenTtoT identifyTdiseaseTstates.
c. NursingT diagnosesT describeT patientT problemsT thatT nursesT treat.
d. NursingT diagnosesT identifyT causesT relatedT toTillness.
ANS:TC
DiagnosticT statementsT identifyT problemsT aT nurseT isT independentlyT ableT toTt
reatT withinTtheT scopeT ofTprofessionalTpractice.T NursingT diagnosesT varyTwit
hTtheTchangingT conditionTofTtheT patient.TTheTresponseT patternsT areTuniqueT
toTtheTpatientT andTareT notTdiseaseT specific.TNursingT diagnosesTdescribeTtheT
patientsT humanTresponseTpattern.
DIF:T CognitiveT Level:T Comprehension
